Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Camp4 Therapeutics Corp changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 29 | 40 | +11 |
| Shares | 28.2M | 38.2M | +10.0M (+35.6%) |
| Value | $84.6M | $234.6M | +$150.0M (+177.2%) |
New holders (13)
Institutions that held Camp4 Therapeutics Corp at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 2,436,900 | $14.9M | 0.03% |
| Trails Edge Capital Partners, LP | 1,983,986 | $12.2M | 3.00% |
| EcoR1 Capital, LLC | 325,000 | $1.99M | 0.09% |
| Stonepine Capital Management, LLC | 228,894 | $1.40M | 1.11% |
| 683 Capital Management, LLC | 126,363 | $774.6K | 0.06% |
| ExodusPoint Capital Management, LP | 34,720 | $212.8K | 0.00% |
| Jane Street Group, LLC | 25,534 | $156.5K | 0.00% |
| Citigroup Inc | 21,403 | $131.2K | 0.00% |
| Goldman Sachs Group Inc | 18,823 | $115.4K | 0.00% |
| Omers Administration Corp | 18,800 | $115.2K | 0.00% |
| Bank of New York Mellon Corp | 18,718 | $114.7K | 0.00% |
| Jefferies Financial Group Inc. | 11,361 | $69.6K | 0.00% |
| China Universal Asset Management Co., Ltd. | 10,000 | $61.3K | 0.00% |
Sold out (2)
Institutions that held Camp4 Therapeutics Corp at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Silverarc Capital Management, LLC | 653,594 | $1.96M |
| CWM, LLC | 5 | $0 |